Antitubercular drugs (isoniazid, rifampin and pyrazinamide): hepatobiliary reactions.
作者信息
Vu D, Macdonald L
出版信息
CMAJ. 2001 Oct 2;165(7):942-3, 946-7.
PMID:11599338
Abstract
摘要
相似文献
1
Antitubercular drugs (isoniazid, rifampin and pyrazinamide): hepatobiliary reactions.抗结核药物（异烟肼、利福平和吡嗪酰胺）：肝胆反应。
CMAJ. 2001 Oct 2;165(7):942-3, 946-7.
2
[Comprehensive view of hepatitis and the other reactions secondary to antituberculosis chemotherapy].[肝炎及抗结核化疗继发的其他反应的综合观点]
Bull Int Union Tuberc. 1980 Mar-Jun;55(1-2):9-13.
3
Antituberculosis drugs and hepatotoxicity.抗结核药物与肝毒性。
Infect Genet Evol. 2004 Jun;4(2):167-70. doi: 10.1016/j.meegid.2003.01.001.
4
[Toxicity of antitubercular agents for the liver].
Dtsch Med Wochenschr. 1973 Jan 12;98(2):74.
5
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trial.短程利福平与吡嗪酰胺对比异烟肼用于潜伏性结核感染：基于多中心临床试验的成本效益分析
Clin Infect Dis. 2004 Jul 15;39(2):289. doi: 10.1086/421783.
6
[Hepatic functional changes induced by the combined use of isoniazid, pyrazinamide and rifampicin in the treatment of pulmonary tuberculosis].异烟肼、吡嗪酰胺和利福平联合使用治疗肺结核引起的肝功能变化
Arq Gastroenterol. 1996 Oct-Dec;33(4):194-200.
7
[Fulminant hepatic failure due to tuberculostatic drugs: case report].[抗结核药物所致暴发性肝衰竭：病例报告]
Arch Argent Pediatr. 2012 May-Jun;110(3):e35-8. doi: 10.5546/aap.2012.e35.
8
Hepatotoxicity of pyrazinamide: cohort and case-control analyses.吡嗪酰胺的肝毒性：队列研究与病例对照分析。
Am J Respir Crit Care Med. 2008 Jun 15;177(12):1391-6. doi: 10.1164/rccm.200802-355OC. Epub 2008 Apr 3.
9
The best approach to reintroducing tuberculosis treatment after hepatotoxicity is still open to debate.肝毒性后重新引入结核病治疗的最佳方法仍存在争议。
Clin Infect Dis. 2010 Aug 1;51(3):366-7; author reply 367-8. doi: 10.1086/654806.
10
[Clinically apparent liver damage during brief tuberculosis therapy].[短期结核病治疗期间的临床明显肝损伤]
Rev Med Chil. 1981 Oct;109(10):941-4.
Zotero 插件